ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Qi Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences and School of Life Sciences, Xiamen University, Xiamen, China; Fujian Provincial Key Laboratory of Innovative Drug …. Hauptthemen laut MEDLINE: Cyclin D2, Glucagon-Secreting Cells, Hyperplasia, Mechanistic Target of Rapamycin Complex 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS, Fujian Provincial Department of Science and Technology.
Abstract (Originalsprache)
Blood amino acid levels are maintained in a narrow physiological range. The pancreatic α cells have emerged as the primary aminoacidemia regulator through glucagon secretion to promote hepatic amino acid catabolism. Interruption of glucagon signaling disrupts the liver-α cells axis leading to hyperaminoacidemia, which triggers a compensatory rise in glucagon secretion and α cell hyperplasia. The mechanisms of hyperaminoacidemia-induced α cell hyperplasia remain incompletely understood. Using a mouse α cell line and in vivo studies in zebrafish and mice, we found that hyperaminoacidemia-induced α cell hyperplasia requires ErbB3 signaling. In addition to mechanistic target of rapamycin complex 1, another ErbB3 downstream effector signal transducer and activator of transcription 3 also plays a role in α cell hyperplasia. Mechanistically, ErbB3 may partner with ErbB2 to stimulate cyclin D2 and suppress p27 via mechanistic target of rapamycin complex 1 and signal transducer and activator of transcription 3. Our study identifies ErbB3 as a new regulator for hyperaminoacidemia-induced α cell proliferation and a critical component of the liver-α cells axis that regulates aminoacidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences and School of Life Sciences, Xiamen University, Xiamen, China; Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University,…
- Departments of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University…
- Departments of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Electronic address: wenbiao.chen@vanderbilt.edu.
Förderung
- BLRD VA
- NIDDK NIH HHS
- Fujian Provincial Department of Science and Technology
- Xiamen City Department of Science and Technology
Zitieren
APA
Kang, Q., Jia, J., Dean, E. D., Yuan, H., Dai, C., Li, Z., Jiang, F., Zhang, X. K., Powers, A. C., Chen, W., & Li, M. (2024). ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107499
Vancouver
Kang Q, Jia J, Dean ED, Yuan H, Dai C, Li Z, et al. ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107499
BibTeX
@article{Kang2024,
author = {Kang, Qi and Jia, Jianxin and Dean, E Danielle and Yuan, Hang and Dai, Chunhua and Li, Zhehui and Jiang, Fuquan and Zhang, Xiao-Kun and Powers, Alvin C and Chen, Wenbiao and Li, Mingyu},
title = {ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107499}
}
EUVIMED